Which has higher valuation and earnings, NXGLW or LUCYW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NEXGEL $12.07M N/A N/A N/A N/A Innovative Eyewear $3.41M N/A N/A N/A N/A

Is NXGLW or LUCYW more profitable?

Company Net Margins Return on Equity Return on Assets NEXGEL N/A N/A N/A Innovative Eyewear N/A N/A N/A

Do analysts rate WOK or LUCYW?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score WORK Medical Technology Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Innovative Eyewear 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger valuation & earnings, WOK or LUCYW?

Innovative Eyewear has lower revenue, but higher earnings than WORK Medical Technology Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio WORK Medical Technology Group $9.81M N/A -$1.07M N/A N/A Innovative Eyewear $3.41M N/A N/A N/A N/A

Is WOK or LUCYW more profitable?

Company Net Margins Return on Equity Return on Assets WORK Medical Technology Group N/A N/A N/A Innovative Eyewear N/A N/A N/A

Do analysts rate MDLN or LUCYW?

Medline currently has a consensus price target of $46.88, indicating a potential upside of 31.66%. Given Medline's stronger consensus rating and higher probable upside, equities analysts clearly believe Medline is more favorable than Innovative Eyewear. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medline 1 Sell rating(s) 5 Hold rating(s) 21 Buy rating(s) 2 Strong Buy rating(s) 2.83 Innovative Eyewear 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation & earnings, MDLN or LUCYW?

Medline has higher revenue and earnings than Innovative Eyewear. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Medline $29.94B 1.56 $1.16B $0.79 45.08 Innovative Eyewear $3.41M N/A N/A N/A N/A

Is MDLN or LUCYW more profitable?

Company Net Margins Return on Equity Return on Assets Medline N/A N/A N/A Innovative Eyewear N/A N/A N/A

Do analysts rate LUCYW or ALC?

Alcon has a consensus price target of $84.97, indicating a potential upside of 33.30%. Given Alcon's stronger consensus rating and higher possible upside, analysts clearly believe Alcon is more favorable than Innovative Eyewear. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Innovative Eyewear 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Alcon 1 Sell rating(s) 6 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.63

Which has stronger valuation and earnings, LUCYW or ALC?

Alcon has higher revenue and earnings than Innovative Eyewear. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Innovative Eyewear $3.41M N/A N/A N/A N/A Alcon $10.40B 3.03 $980M $1.31 48.66

Which has higher valuation and earnings, WST or LUCYW?

West Pharmaceutical Services has higher revenue and earnings than Innovative Eyewear. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio West Pharmaceutical Services $3.07B 8.37 $493.70M $7.81 46.81 Innovative Eyewear $3.41M N/A N/A N/A N/A

Innovative Eyewear (LUCYW) Competitors

$0.04 +0.01 (+38.33%)

As of 12:08 PM Eastern

Compare

LUCYW vs. NXGLW, WOK, MDLN, ALC, and WST

Should you buy Innovative Eyewear stock or one of its competitors? Innovative Eyewear's main competitors and comparable companies include NEXGEL (NXGLW), WORK Medical Technology Group (WOK), Medline (MDLN), Alcon (ALC), and West Pharmaceutical Services (WST). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Innovative Eyewear compare to NEXGEL?

NEXGEL (NASDAQ:NXGLW) and Innovative Eyewear (NASDAQ:LUCYW) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NEXGEL	$12.07M	N/A	N/A	N/A	N/A
Innovative Eyewear	$3.41M	N/A	N/A	N/A	N/A

In the previous week, NEXGEL's average media sentiment score of 0.98 beat Innovative Eyewear's score of 0.00 indicating that NEXGEL is being referred to more favorably in the media.

Company	Overall Sentiment
NEXGEL	Positive
Innovative Eyewear	Neutral

Company	Net Margins	Return on Equity	Return on Assets
NEXGEL	N/A	N/A	N/A
Innovative Eyewear	N/A	N/A	N/A

Summary

NEXGEL beats Innovative Eyewear on 2 of the 2 factors compared between the two stocks.

How does Innovative Eyewear compare to WORK Medical Technology Group?

WORK Medical Technology Group (NASDAQ:WOK) and Innovative Eyewear (NASDAQ:LUCYW) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

Innovative Eyewear has lower revenue, but higher earnings than WORK Medical Technology Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
WORK Medical Technology Group	$9.81M	N/A	-$1.07M	N/A	N/A
Innovative Eyewear	$3.41M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
WORK Medical Technology Group	N/A	N/A	N/A
Innovative Eyewear	N/A	N/A	N/A

In the previous week, WORK Medical Technology Group's average media sentiment score of 0.00 equaled Innovative Eyewear'saverage media sentiment score.

Company	Overall Sentiment
WORK Medical Technology Group	Neutral
Innovative Eyewear	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
WORK Medical Technology Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Innovative Eyewear	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

WORK Medical Technology Group beats Innovative Eyewear on 2 of the 2 factors compared between the two stocks.

How does Innovative Eyewear compare to Medline?

Medline (NASDAQ:MDLN) and Innovative Eyewear (NASDAQ:LUCYW) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

Company	Net Margins	Return on Equity	Return on Assets
Medline	N/A	N/A	N/A
Innovative Eyewear	N/A	N/A	N/A

Medline has higher revenue and earnings than Innovative Eyewear.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medline	$29.94B	1.56	$1.16B	$0.79	45.08
Innovative Eyewear	$3.41M	N/A	N/A	N/A	N/A

In the previous week, Medline had 13 more articles in the media than Innovative Eyewear. MarketBeat recorded 13 mentions for Medline and 0 mentions for Innovative Eyewear. Medline's average media sentiment score of 0.10 beat Innovative Eyewear's score of 0.00 indicating that Medline is being referred to more favorably in the media.

Company	Overall Sentiment
Medline	Neutral
Innovative Eyewear	Neutral

Medline currently has a consensus price target of $46.88, indicating a potential upside of 31.66%. Given Medline's stronger consensus rating and higher probable upside, equities analysts clearly believe Medline is more favorable than Innovative Eyewear.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medline	1 Sell rating(s)	5 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.83
Innovative Eyewear	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Medline beats Innovative Eyewear on 7 of the 7 factors compared between the two stocks.

How does Innovative Eyewear compare to Alcon?

Innovative Eyewear (NASDAQ:LUCYW) and Alcon (NYSE:ALC) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

In the previous week, Alcon had 6 more articles in the media than Innovative Eyewear. MarketBeat recorded 6 mentions for Alcon and 0 mentions for Innovative Eyewear. Alcon's average media sentiment score of 0.26 beat Innovative Eyewear's score of 0.00 indicating that Alcon is being referred to more favorably in the news media.

Company	Overall Sentiment
Innovative Eyewear	Neutral
Alcon	Neutral

Alcon has a consensus price target of $84.97, indicating a potential upside of 33.30%. Given Alcon's stronger consensus rating and higher possible upside, analysts clearly believe Alcon is more favorable than Innovative Eyewear.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Innovative Eyewear	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Alcon	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.63

Alcon has higher revenue and earnings than Innovative Eyewear.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Innovative Eyewear	$3.41M	N/A	N/A	N/A	N/A
Alcon	$10.40B	3.03	$980M	$1.31	48.66

53.9% of Alcon shares are owned by institutional investors. 1.5% of Alcon shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Alcon has a net margin of 5.92% compared to Innovative Eyewear's net margin of 0.00%. Alcon's return on equity of 7.29% beat Innovative Eyewear's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Innovative Eyewear	N/A	N/A	N/A
Alcon	5.92%	7.29%	5.09%

Summary

Alcon beats Innovative Eyewear on 12 of the 12 factors compared between the two stocks.

How does Innovative Eyewear compare to West Pharmaceutical Services?

West Pharmaceutical Services (NYSE:WST) and Innovative Eyewear (NASDAQ:LUCYW) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.

West Pharmaceutical Services currently has a consensus target price of $382.00, indicating a potential upside of 4.50%. Given West Pharmaceutical Services' stronger consensus rating and higher possible upside, equities analysts clearly believe West Pharmaceutical Services is more favorable than Innovative Eyewear.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
West Pharmaceutical Services	0 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.86
Innovative Eyewear	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

West Pharmaceutical Services has a net margin of 16.98% compared to Innovative Eyewear's net margin of 0.00%. West Pharmaceutical Services' return on equity of 20.11% beat Innovative Eyewear's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
West Pharmaceutical Services	16.98%	20.11%	14.83%
Innovative Eyewear	N/A	N/A	N/A

West Pharmaceutical Services has higher revenue and earnings than Innovative Eyewear.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
West Pharmaceutical Services	$3.07B	8.37	$493.70M	$7.81	46.81
Innovative Eyewear	$3.41M	N/A	N/A	N/A	N/A

93.9% of West Pharmaceutical Services shares are owned by institutional investors. 0.6% of West Pharmaceutical Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, West Pharmaceutical Services had 2 more articles in the media than Innovative Eyewear. MarketBeat recorded 2 mentions for West Pharmaceutical Services and 0 mentions for Innovative Eyewear. West Pharmaceutical Services' average media sentiment score of 0.45 beat Innovative Eyewear's score of 0.00 indicating that West Pharmaceutical Services is being referred to more favorably in the media.

Company	Overall Sentiment
West Pharmaceutical Services	Neutral
Innovative Eyewear	Neutral

Summary

West Pharmaceutical Services beats Innovative Eyewear on 11 of the 11 factors compared between the two stocks.

Get Innovative Eyewear News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LUCYW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LUCYW vs. The Competition

Export

Metric	Innovative Eyewear	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$5.48B	$7.14B	$13.10B
Dividend Yield	N/A	1.81%	2.54%	16.76%
P/E Ratio	N/A	24.55	273.67	26.04
Price / Sales	N/A	67.76	611.82	91.49
Price / Cash	N/A	32.43	77.60	51.75
Price / Book	N/A	5.68	10.92	6.30
Net Income	N/A	$152.11M	$3.50B	$361.43M
7 Day Performance	N/A	-2.01%	-2.11%	-1.67%
1 Month Performance	N/A	-5.42%	-6.34%	-3.94%
1 Year Performance	N/A	2.75%	8.81%	2.77%

Innovative Eyewear Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LUCYW Innovative Eyewear	N/A	$0.04 +38.3%	N/A	-48.8%	$0.00	$3.41M	N/A	13	High Trading Volume
NXGLW NEXGEL	N/A	$0.01 +8.1%	N/A	-94.7%	$0.00	$12.07M	N/A	10
WOK WORK Medical Technology Group	N/A	$1.90 +0.5%	N/A	-100.0%	$0.00	$9.81M	N/A	226
MDLN Medline	2.9478 of 5 stars	$34.43 +7.7%	$47.42 +37.7%	N/A	$42.02B	$28.43B	43.58	45,000
ALC Alcon	3.4083 of 5 stars	$65.57 +1.1%	$84.97 +29.6%	-14.8%	$32.09B	$10.40B	50.06	25,942

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LUCYW) was last updated on 10/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Innovative Eyewear (LUCYW) Competitors

LUCYW vs. NXGLW, WOK, MDLN, ALC, and WST

How does Innovative Eyewear compare to NEXGEL?

Summary

How does Innovative Eyewear compare to WORK Medical Technology Group?

Summary

How does Innovative Eyewear compare to Medline?

Summary

How does Innovative Eyewear compare to Alcon?

Summary

How does Innovative Eyewear compare to West Pharmaceutical Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LUCYW vs. The Competition

Innovative Eyewear Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Innovative Eyewear (LUCYW) Competitors

LUCYW vs. NXGLW, WOK, MDLN, ALC, and WST

How does Innovative Eyewear compare to NEXGEL?

Which has higher valuation and earnings, NXGLW or LUCYW?

Does the media favor NXGLW or LUCYW?

Is NXGLW or LUCYW more profitable?

Summary

How does Innovative Eyewear compare to WORK Medical Technology Group?

Which has stronger valuation & earnings, WOK or LUCYW?

Is WOK or LUCYW more profitable?

Does the media refer more to WOK or LUCYW?

Do analysts rate WOK or LUCYW?

Summary

How does Innovative Eyewear compare to Medline?

Is MDLN or LUCYW more profitable?

Which has higher valuation & earnings, MDLN or LUCYW?

Does the media favor MDLN or LUCYW?

Do analysts rate MDLN or LUCYW?

Summary

How does Innovative Eyewear compare to Alcon?

Does the media prefer LUCYW or ALC?

Do analysts rate LUCYW or ALC?

Which has stronger valuation and earnings, LUCYW or ALC?

Do institutionals & insiders believe in LUCYW or ALC?

Is LUCYW or ALC more profitable?

Summary

How does Innovative Eyewear compare to West Pharmaceutical Services?

Do analysts rate WST or LUCYW?

Is WST or LUCYW more profitable?

Which has higher valuation and earnings, WST or LUCYW?

Do insiders and institutionals have more ownership in WST or LUCYW?

Does the media favor WST or LUCYW?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LUCYW vs. The Competition

Innovative Eyewear Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools